feed,title,long_url,short_url
Benzinga,Fate Therapeutics Initiated With Hold Rating - Read Why,https://benzinga.com/general/biotech/22/07/28252312/fate-therapeutics-initiated-with-hold-rating-read-more,https://bit.ly/3zE2Hzd
Benzinga,Teladoc Health's Revised Outlook 'Implies More Downside' According To This Analyst,https://benzinga.com/news/earnings/22/07/28253036/this-analyst-says-teladoc-healths-revised-outlook-implies-more-downside,https://bit.ly/3BpShEE
